Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-02 4:19 pm Sale |
2024-01-02 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 24,788 6.500% |
-4,102 (-14.20%) |
Filing History |
| 2023-11-17 11:32 am Purchase |
2023-11-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 28,889 7.600% |
4,417 (+18.05%) |
Filing History |
| 2023-11-06 11:35 am Purchase |
2023-11-06 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 24,473 6.400% |
24,473 (New Position) |
Filing History |
| 2023-08-07 07:00 am Purchase |
2023-08-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 23,295 10.700% |
2,273 (+10.81%) |
Filing History |
| 2023-07-17 07:00 am Purchase |
2023-07-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 21,023 11.100% |
2,244 (+11.95%) |
Filing History |
| 2023-07-07 07:00 am Purchase |
2023-07-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 18,778 9.900% |
2,699 (+16.78%) |
Filing History |
| 2023-06-30 08:40 am Purchase |
2023-06-30 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 16,080 8.500% |
625 (+4.04%) |
Filing History |
| 2023-06-22 2:49 pm Purchase |
2023-06-22 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Ruck Matthew J | 9,659 6.180% |
551 (+6.05%) |
Filing History |
| 2023-06-14 2:42 pm Unchanged |
2023-06-14 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Ruck Matthew J | 9,108 5.830% |
0 (Unchanged) |
Filing History |
| 2023-06-14 10:41 am Purchase |
2023-06-14 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Ruck Matthew J | 9,108 5.830% |
316 (+3.59%) |
Filing History |
| 2023-06-12 10:39 am Purchase |
2023-06-12 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 15,455 9.900% |
2,386 (+18.26%) |
Filing History |
| 2023-06-09 10:42 am Purchase |
2023-06-08 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Ruck Matthew J | 8,792 5.600% |
8,792 (New Position) |
Filing History |
| 2023-05-26 10:23 am Purchase |
2023-05-25 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 13,068 8.400% |
2,382 (+22.29%) |
Filing History |
| 2023-05-17 3:49 pm Purchase |
2023-05-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 10,687 6.850% |
3,184 (+42.43%) |
Filing History |
| 2023-05-01 9:49 pm Purchase |
2023-04-28 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 7,503 6.500% |
7,503 (New Position) |
Filing History |
| 2023-02-10 4:40 pm Purchase |
2022-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Hudson Bay Capital Management LP | 1,380 2.970% |
1,380 (New Position) |
Filing History |
| 2022-02-03 2:30 pm Purchase |
2021-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Hudson Bay Capital Management LP | 1,380 5.340% |
1,380 (New Position) |
Filing History |
| 2021-03-10 07:51 am Purchase |
2020-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Mohan Pankaj | 383 5.500% |
383 (New Position) |
Filing History |
| 2021-02-16 3:53 pm Unchanged |
2020-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Arena Investors, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Altium Capital Management LLC | 2,299 4.990% |
2,081 (+952.75%) |
Filing History |